MaltSci 麦伴科研

Appearance

Popular Reports / cell-biology

This report is written by MaltSci based on the latest literature and research findings

How does DNA damage response maintain genome stability? ​

Abstract ​

The integrity and stability of the genome are essential for the proper functioning of all living organisms, as DNA is continually subjected to damage from various intrinsic and extrinsic factors. The DNA damage response (DDR) is a complex network of signaling pathways that detect and repair DNA lesions, thereby preserving genetic information and preventing diseases such as cancer. This review explores the multifaceted roles of the DDR in maintaining genome stability, beginning with an overview of the sources and types of DNA damage, including single-strand breaks, double-strand breaks, and base modifications. Key components of the DDR, such as ATM and ATR kinases, p53, BRCA1, and RAD51, are examined in detail, emphasizing their roles in sensing DNA damage, activating repair mechanisms, and regulating cell cycle progression. The consequences of DDR failure, particularly its implications for cancer development and aging, are also discussed. Moreover, the review highlights the interactions between the DDR and other cellular processes, including apoptosis, senescence, and immune responses. By synthesizing current knowledge of the DDR and its implications for genome stability, this review aims to identify critical areas for future research and therapeutic development, ultimately underscoring the importance of the DDR in maintaining cellular health and its potential as a target for innovative cancer therapies.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Overview of DNA Damage and its Types
    • 2.1 Sources of DNA Damage
    • 2.2 Types of DNA Lesions
  • 3 The DNA Damage Response Pathways
    • 3.1 Sensing DNA Damage
    • 3.2 Signal Transduction Mechanisms
    • 3.3 Activation of DNA Repair Pathways
  • 4 Key Proteins in the DNA Damage Response
    • 4.1 ATM and ATR Kinases
    • 4.2 p53 and its Role in Cell Cycle Regulation
    • 4.3 Repair Proteins: BRCA1, RAD51, and Others
  • 5 Consequences of DNA Damage Response Failure
    • 5.1 Implications for Cancer Development
    • 5.2 Aging and Genomic Instability
    • 5.3 Therapeutic Targets in DDR
  • 6 Interaction of DDR with Other Cellular Processes
    • 6.1 Apoptosis and Senescence
    • 6.2 Immune Response and DDR
    • 6.3 Metabolic Regulation and DDR
  • 7 Conclusion

1 Introduction ​

The integrity and stability of the genome are paramount for the proper functioning of all living organisms. DNA is continually subjected to damage from a myriad of intrinsic and extrinsic factors, including replication errors, oxidative stress, and exposure to environmental agents such as radiation and chemicals [1][2]. This incessant threat to genomic integrity necessitates robust cellular mechanisms to detect and repair DNA lesions, thereby preserving genetic information and preventing diseases such as cancer [3][4]. The DNA damage response (DDR) is a complex network of signaling pathways that orchestrates the detection of DNA damage, activates repair mechanisms, and regulates cell cycle progression [5][6]. Understanding the multifaceted roles of the DDR is crucial, not only for elucidating the mechanisms of genome stability but also for developing therapeutic strategies against diseases associated with genomic instability [7][8].

The significance of the DDR extends beyond mere repair; it encompasses a spectrum of cellular responses that influence cell fate decisions, including apoptosis, senescence, and differentiation [3][9]. When the DDR functions optimally, it safeguards against mutations and chromosomal aberrations, which are hallmarks of cancer [10][11]. Conversely, failures in the DDR can lead to unchecked cellular proliferation and genomic instability, contributing to tumorigenesis and other pathologies [12][13]. Thus, the DDR serves as both a guardian of genomic integrity and a potential target for therapeutic intervention, especially in the context of cancer treatment [4][7].

Current research has identified several key components of the DDR, including sensor proteins, transducers, and effectors, that play critical roles in the response to DNA damage [5][6]. Proteins such as ATM and ATR kinases are central to the signaling cascade that activates repair pathways [3][5]. Furthermore, the tumor suppressor p53 is integral to regulating cell cycle checkpoints and facilitating apoptosis in response to severe DNA damage [3][4]. Other important players include BRCA1 and RAD51, which are essential for homologous recombination repair, a critical pathway for repairing double-strand breaks [4][12].

This review will systematically explore the mechanisms by which the DDR maintains genome stability. The first section will provide an overview of the types and sources of DNA damage, highlighting both endogenous and exogenous factors [1][2]. Following this, we will delve into the intricate DDR pathways, discussing how DNA damage is sensed, the signal transduction mechanisms involved, and the activation of various DNA repair pathways [3][9]. Key proteins involved in the DDR will be examined in detail, including the roles of ATM, ATR, p53, and repair proteins such as BRCA1 and RAD51 [3][5].

Subsequently, we will address the consequences of DDR failure, particularly its implications for cancer development, aging, and potential therapeutic targets [10][12]. The interaction of the DDR with other cellular processes, including apoptosis, senescence, and immune responses, will also be discussed, emphasizing the interconnectedness of these pathways [3][9].

By synthesizing the current understanding of the DDR and its implications for genome stability, this review aims to illuminate critical areas for future research and therapeutic development. The insights gained may pave the way for innovative strategies to combat diseases associated with genomic instability, particularly cancer [7][8]. Through this comprehensive exploration, we hope to underscore the importance of the DDR in maintaining cellular health and its potential as a target for future interventions in cancer therapy.

2 Overview of DNA Damage and its Types ​

2.1 Sources of DNA Damage ​

The DNA damage response (DDR) is a critical mechanism that maintains genome stability by detecting and repairing DNA lesions, thereby preventing the accumulation of mutations that can lead to various diseases, including cancer. This response involves a complex network of signaling pathways that are activated upon the recognition of DNA damage, leading to processes such as cell cycle arrest, DNA repair, and, if the damage is irreparable, apoptosis or senescence.

DNA damage can arise from various sources, including environmental factors (such as radiation and chemicals) and endogenous processes (like metabolic byproducts). These damaging agents can induce different types of DNA lesions, with double-strand breaks (DSBs) being among the most severe. DSBs can lead to chromosomal rearrangements and genomic instability if not accurately repaired [3][14][15].

The DDR operates through several key mechanisms. Initially, damage sensors detect the lesions, triggering a cascade of signaling events that activate transducer proteins, which amplify the damage signal and coordinate the cellular response. Key players in this process include protein kinases such as ATM (Ataxia Telangiectasia Mutated) and ATR (ATM and Rad3-related), which are pivotal in orchestrating the DDR by regulating downstream effectors involved in DNA repair and cell cycle control [5][9].

Moreover, the DDR is not merely a reactive process; it also involves a surveillance system that monitors DNA integrity throughout the cell cycle. This surveillance is crucial for ensuring that cells do not proceed through division with damaged DNA, which could lead to genomic instability and tumorigenesis [3][3].

In the context of maintaining genome stability, the DDR is essential for preventing the propagation of damaged DNA during cell division. If the repair mechanisms fail, the accumulated DNA damage can lead to cellular senescence, apoptosis, or even oncogenesis. In cancer cells, the DDR pathways can become dysregulated, allowing these cells to survive despite significant genomic instability, which contributes to tumor progression [4][10].

Furthermore, recent research highlights the involvement of noncoding RNAs in the DDR, which play a role in regulating DNA repair processes and maintaining genome integrity. These molecules are increasingly recognized as important regulators of the DDR pathway, particularly in response to DSBs [16][17].

In summary, the DNA damage response is a multifaceted system that detects, signals, and repairs DNA damage to preserve genome stability. Its effectiveness is critical for preventing the deleterious consequences of DNA lesions, which can lead to mutations and diseases such as cancer. Understanding the DDR's mechanisms and its interplay with various cellular processes is essential for developing targeted therapies aimed at enhancing genome stability and combating cancer.

2.2 Types of DNA Lesions ​

The DNA damage response (DDR) is a crucial mechanism that maintains genome stability by detecting and repairing DNA lesions, which can arise from both endogenous and exogenous sources. DNA lesions encompass a variety of damage types, including single-strand breaks, double-strand breaks (DSBs), base modifications, and interstrand crosslinks. Each of these lesions poses a different level of threat to genomic integrity and requires specific repair mechanisms to restore DNA function.

  1. Overview of DNA Damage: DNA damage occurs continuously in cells due to factors such as replication errors, oxidative stress, exposure to ultraviolet (UV) light, ionizing radiation, and chemical agents. The persistence of unrepaired DNA lesions can lead to mutations, chromosomal rearrangements, and ultimately, diseases such as cancer. The DDR encompasses a series of cellular processes that respond to DNA damage, including damage recognition, signaling, and repair. These processes are tightly regulated and involve numerous proteins and pathways that work together to ensure the fidelity of the genome.

  2. Types of DNA Lesions: DNA lesions can be classified into several categories:

    • Single-Strand Breaks (SSBs): These occur when one of the two strands of the DNA helix is severed. SSBs can be repaired by base excision repair (BER) or by the action of poly(ADP-ribose) polymerase (PARP) enzymes.

    • Double-Strand Breaks (DSBs): DSBs are particularly harmful as they can lead to the loss of genetic information if not repaired correctly. DSBs can arise from various sources, including ionizing radiation and certain chemotherapeutic agents. The repair of DSBs primarily involves homologous recombination (HR) and non-homologous end joining (NHEJ) pathways, which are essential for maintaining genome integrity and preventing genomic instability [2].

    • Base Modifications: These include oxidative damage to bases, such as 8-oxoguanine, which can mispair during DNA replication, leading to mutations. The repair of these lesions typically involves nucleotide excision repair (NER) or base excision repair (BER) mechanisms.

    • Interstrand Crosslinks (ICLs): ICLs prevent the separation of DNA strands, thereby blocking replication and transcription. The repair of ICLs is complex and involves a coordinated response that includes homologous recombination and translesion synthesis [12].

The DDR operates through a sophisticated network of signaling pathways that involve sensor proteins, transducers, and effectors. Key proteins, such as ATM and ATR kinases, play a central role in detecting DNA damage and initiating repair processes. Upon detection of damage, these kinases activate downstream signaling cascades that lead to cell cycle arrest, allowing time for repair to occur. If the damage is irreparable, the DDR can trigger programmed cell death (apoptosis) to prevent the propagation of damaged cells [5].

In summary, the DNA damage response is vital for maintaining genome stability through the detection and repair of various types of DNA lesions. By orchestrating a coordinated response to DNA damage, the DDR ensures that cells can effectively manage genomic threats, thus preventing mutations and the potential development of cancer [3][4][10].

3 The DNA Damage Response Pathways ​

3.1 Sensing DNA Damage ​

The maintenance of genome stability is critically dependent on the DNA damage response (DDR), a sophisticated network of signaling pathways that detect DNA lesions and initiate repair mechanisms. This response is essential for preserving genetic integrity and preventing mutations that can lead to diseases such as cancer. The DDR comprises multiple layers of regulation, which ensure that cells can effectively respond to various types of DNA damage, including double-strand breaks (DSBs), single-strand breaks, and other lesions caused by environmental and endogenous factors.

When DNA damage occurs, the first step in the DDR is the detection of the damage by specialized sensor proteins. For instance, proteins such as ATM (Ataxia Telangiectasia Mutated) and ATR (ATM and Rad3-related) are pivotal in recognizing DNA damage and activating downstream signaling pathways. These kinases are activated in response to specific types of DNA lesions and play distinct roles in orchestrating the cellular response to damage [18]. Once activated, ATM and ATR initiate a cascade of signaling events that result in the recruitment of various repair proteins to the site of damage, amplifying the damage signal and coordinating the cellular response [5].

Following the detection of DNA damage, the DDR pathways engage in several critical processes. These include halting the cell cycle to prevent the propagation of damaged DNA, activating DNA repair mechanisms, and, if the damage is irreparable, inducing programmed cell death (apoptosis) or cellular senescence [12]. The precise outcome depends on the extent of the damage and the efficiency of the repair processes. For example, if a cell can successfully repair the damage, it may resume normal function. However, if the damage is too severe, the DDR will trigger pathways leading to cell death to eliminate the potential for tumorigenesis [19].

Moreover, the DDR is also involved in modulating other cellular processes, such as metabolism and gene expression, to ensure that the cellular environment is conducive to effective repair [20]. This includes the involvement of noncoding RNAs and various protein modifiers that can influence the activity of key proteins in the DDR, further highlighting the complexity and adaptability of this response [16].

In summary, the DNA damage response plays a fundamental role in maintaining genome stability by rapidly sensing DNA damage, orchestrating repair processes, and making critical decisions regarding cell fate. This multifaceted response is crucial for preventing genomic instability, which is a hallmark of many cancers and other genetic disorders. The coordinated action of various proteins and signaling pathways ensures that cells can effectively manage DNA damage and maintain the integrity of their genetic material over time.

3.2 Signal Transduction Mechanisms ​

The DNA damage response (DDR) is a critical network of signaling pathways that maintains genomic stability by detecting and repairing DNA lesions. This complex system involves multiple mechanisms that ensure cellular integrity and proper function in response to various types of DNA damage caused by both endogenous and exogenous factors.

At the core of the DDR are sensor proteins that identify DNA damage, such as double-strand breaks (DSBs), and activate a cascade of signaling events. These signaling pathways are primarily regulated by protein phosphorylation, which modulates the activity of various downstream effectors involved in the DNA repair process. Key proteins such as ATM (Ataxia Telangiectasia Mutated) and ATR (ATM and Rad3-related) play pivotal roles in orchestrating these responses, ensuring that cells either repair the damage or undergo apoptosis if the damage is irreparable [5].

The DDR can be divided into several components, including the DNA damage surveillance system and the DNA repair system. The surveillance system detects DNA damage and transmits signals to activate repair pathways, while the repair system executes the actual repair processes. This two-tiered approach is essential for maintaining genomic integrity under stress [8].

Cell cycle checkpoints are integral to the DDR, as they provide the necessary pauses in the cell cycle to allow for DNA repair before progression to the next phase. For instance, in mammalian cells, the G1, S, and G2 checkpoints are activated in response to DNA damage, which prevents the cell from advancing through the cycle until the damage is addressed [21]. This function is crucial in preventing the propagation of mutations that could lead to cancer.

Moreover, the DDR is tightly linked to cellular responses such as apoptosis and senescence. When DNA damage is detected, the DDR can trigger cell cycle arrest, allowing time for repair. However, if the damage is extensive and beyond repair, the DDR can initiate programmed cell death to eliminate potentially harmful cells [14]. This aspect of the DDR is vital for preventing genomic instability, which is a recognized precursor to tumorigenesis [22].

The regulation of transcription also plays a significant role in the DDR. Recent studies indicate that transcriptional changes occur in response to DNA damage, with certain genes being activated while others are silenced. This reprogramming of transcription is essential for the efficient repair of DNA lesions and the maintenance of genome stability [23]. The coordination between transcriptional activity and the DDR highlights the complexity of cellular responses to DNA damage.

In summary, the DNA damage response maintains genome stability through a sophisticated network of signaling pathways that involve damage detection, signal transduction, cell cycle regulation, and repair mechanisms. By ensuring that DNA lesions are properly addressed and that damaged cells are either repaired or eliminated, the DDR serves as a crucial safeguard against genomic instability and the development of cancer.

3.3 Activation of DNA Repair Pathways ​

The DNA damage response (DDR) is a crucial set of signaling pathways that are activated upon the detection of DNA damage, serving to maintain genomic stability. This response encompasses various mechanisms that not only facilitate the repair of damaged DNA but also regulate cell cycle progression, transcription, apoptosis, and senescence. Upon sensing DNA damage, cells can initiate a multi-faceted DDR, which leads to restoration of cellular integrity, senescence, or programmed cell death, depending on the extent of the damage and the cell's ability to repair it [12].

When DNA damage occurs, particularly double-strand breaks (DSBs), cells employ several DNA repair pathways to restore genomic integrity. The two primary repair mechanisms are homologous recombination (HR) and non-homologous end joining (NHEJ). HR is particularly important in repairing DSBs during the S and G2 phases of the cell cycle, utilizing a homologous template for accurate repair. In contrast, NHEJ operates throughout the cell cycle and is critical for repairing DSBs when homologous templates are unavailable [24].

The DDR pathways are activated through the recognition of DNA lesions by sensor proteins, which subsequently initiate signaling cascades involving various kinases, such as ATM (Ataxia Telangiectasia Mutated) and ATR (ATM and Rad3-related). These kinases play pivotal roles in orchestrating the cellular response to DNA damage. They activate downstream effectors that facilitate DNA repair, promote cell cycle arrest, and trigger apoptosis if the damage is irreparable [5].

In the context of cancer, defects in DDR pathways can lead to genomic instability, a hallmark of cancer cells. Tumor cells often exhibit a reliance on specific repair mechanisms, such as HR, to survive the high levels of DNA damage they accumulate, whether from intrinsic factors or therapeutic interventions. For instance, approximately half of high-grade serous ovarian carcinomas show deficiencies in HR, which correlates with their progression and resistance to chemotherapy [25].

Furthermore, recent research highlights the potential of targeting DDR pathways as a therapeutic strategy. By inhibiting specific components of the DDR, such as RAD52, which is essential for HR, it may be possible to selectively induce tumor cell death by pushing genomic instability beyond a viable threshold [12]. This therapeutic approach takes advantage of the inherent weaknesses in cancer cells' DNA repair mechanisms while sparing normal cells that possess intact DDR pathways.

In summary, the DNA damage response plays a fundamental role in maintaining genome stability by activating DNA repair pathways that correct damage and prevent the accumulation of mutations. The interplay between various DDR components and repair mechanisms is critical for cellular survival, particularly under genotoxic stress, and represents a significant focus for therapeutic intervention in cancer treatment.

4 Key Proteins in the DNA Damage Response ​

4.1 ATM and ATR Kinases ​

The DNA damage response (DDR) is a critical cellular mechanism that maintains genome stability by orchestrating a series of signaling pathways that detect, signal, and repair DNA damage. Two key protein kinases involved in this process are ataxia telangiectasia mutated (ATM) and ATM and Rad3-related (ATR). Both kinases play vital roles in responding to various types of DNA damage, ensuring cellular integrity and survival.

ATM is primarily activated in response to DNA double-strand breaks (DSBs), while ATR is crucial for responding to replication stress and single-stranded DNA (ssDNA) regions that arise during DNA replication. Upon activation, ATM and ATR initiate a cascade of phosphorylation events that lead to cell cycle arrest, DNA repair, or apoptosis, depending on the extent of the damage. This process is essential for preventing the accumulation of genetic mutations that could lead to tumorigenesis [26].

ATM and ATR function within a complex network that integrates cell-cycle control with DNA repair mechanisms. They activate downstream targets that include checkpoint kinases such as Chk1 and Chk2, which further mediate cell cycle checkpoints. This ensures that damaged DNA is either repaired before the cell proceeds to division or that the damaged cells are eliminated through apoptosis [27].

The interplay between ATM and ATR is critical for maintaining genome integrity. For instance, during neurogenesis, DNA-PKcs, ATM, and ATR work together to ensure genome stability. ATR has been shown to coordinate the DDR by directing apoptosis in cycling neural progenitors, while ATM regulates apoptosis in noncycling cells [28]. This illustrates that ATM and ATR not only share overlapping functions but also have distinct roles that are crucial for the cellular response to different types of DNA damage [29].

Furthermore, the signaling pathways activated by ATM and ATR can also influence other cellular processes such as transcription and replication, linking the DDR to broader cellular functions. This coordination is vital for preventing genomic instability, which can result from improper DNA repair mechanisms or unchecked cell division [18].

In summary, the DDR, primarily mediated by ATM and ATR kinases, is essential for maintaining genome stability. By detecting DNA damage and orchestrating appropriate repair mechanisms or apoptosis, these kinases help prevent the propagation of damaged DNA, thus safeguarding cellular integrity and preventing the onset of cancer [30][31].

4.2 p53 and its Role in Cell Cycle Regulation ​

The DNA damage response (DDR) is a critical mechanism that maintains genome stability by detecting and repairing DNA damage, thereby preventing mutations that could lead to cancer and other diseases. Central to the DDR is the tumor suppressor protein p53, often referred to as the "guardian of the genome." p53 plays a multifaceted role in responding to DNA damage, influencing cellular outcomes through various pathways.

Upon DNA damage, p53 is activated through a series of post-translational modifications that stabilize the protein and enhance its function as a transcription factor. This activation leads to the regulation of several critical processes, including cell cycle checkpoints, DNA repair, and apoptosis. Specifically, p53 can initiate cell cycle arrest, allowing cells to pause at the G1/S and G2/M checkpoints. This temporary halt in cell proliferation provides the necessary time for DNA repair mechanisms to address the damage, thus preventing the propagation of mutated cells (Zhang et al., 2024) [32].

Moreover, p53 promotes the activation of various DNA repair pathways, such as base excision repair and nucleotide excision repair, ensuring the integrity of the genetic material. If the DNA damage is too severe to be repaired, p53 triggers apoptosis to eliminate potentially cancerous cells, thereby maintaining genomic stability (Erol, 2011) [33].

The interplay between p53 and other cellular factors is crucial for the effectiveness of the DDR. For instance, p53 interacts with cyclin-dependent kinase inhibitors (CDKIs) and other anti-proliferative factors to regulate cell cycle progression in response to DNA damage. This complex signaling network is essential for determining cellular fates such as quiescence, apoptosis, oncogenesis, and senescence (Nicolai et al., 2015) [34].

In addition to its role in cell cycle regulation, p53 is involved in the modulation of genes that facilitate DNA repair processes. It can also influence the decision-making process regarding whether a cell should undergo apoptosis or repair the damage, thereby playing a pivotal role in tumor suppression (Rodier et al., 2007) [35]. This dual role highlights the importance of p53 in balancing the need for cellular repair and the prevention of tumorigenesis.

The dysfunction of p53, often due to mutations in the TP53 gene, can lead to a failure in these critical processes, resulting in cells with damaged genomes continuing to proliferate, which fuels cancer development (Vaddavalli & Schumacher, 2022) [36]. Therefore, therapeutic strategies targeting the p53 pathway are being explored to restore its function in cancer treatment, emphasizing its importance in maintaining genomic stability and preventing tumorigenesis (Williams & Schumacher, 2016) [37].

In summary, the DNA damage response, particularly through the actions of p53, plays a vital role in maintaining genome stability by regulating cell cycle checkpoints, promoting DNA repair, and initiating apoptosis when necessary. This intricate balance is essential for preventing the development of cancer and ensuring the integrity of the cellular genome.

4.3 Repair Proteins: BRCA1, RAD51, and Others ​

The DNA damage response (DDR) is a critical cellular mechanism that maintains genome stability by detecting and repairing DNA lesions, thereby preventing genomic alterations that could lead to diseases such as cancer. Key proteins involved in this response include BRCA1, RAD51, and others, which play significant roles in various repair pathways.

BRCA1 is essential for maintaining genomic stability through its involvement in the assembly of protein complexes that facilitate DNA repair, cell-cycle arrest, and transcriptional regulation. Mutations in BRCA1 are associated with a heightened risk of breast and ovarian cancers. Specifically, BRCA1 interacts with several components of the mRNA-splicing machinery, forming a complex that regulates pre-mRNA splicing in response to DNA damage. This regulation is crucial for stabilizing transcripts and proteins involved in DNA damage signaling and repair, thus promoting genomic stability. The disruption of this BRCA1-mRNA splicing complex leads to increased sensitivity to DNA damage and defective DNA repair, highlighting its vital role in the cellular response to genomic insults [38].

RAD51 is another pivotal protein in the DDR, particularly in the homologous recombination (HR) repair pathway, which is crucial for repairing double-strand breaks (DSBs) in DNA. Upon DNA damage, RAD51 relocalizes to form foci in the nucleus, which are sites where repair processes occur. The formation of these RAD51 foci is dependent on BRCA2 and a set of RAD51 paralogues, indicating a coordinated assembly of proteins at the sites of damage. BRCA2 is known to enhance RAD51's ability to bind DNA, thereby facilitating the repair process. Furthermore, RAD51 not only participates in DSB repair but also plays a protective role during DNA replication by safeguarding and restarting stalled replication forks [39][40].

The interplay between BRCA1 and RAD51 is essential for effective DNA repair and maintaining genome integrity. For instance, BRCA1's role in stabilizing RAD51 at replication forks underscores the importance of this relationship in preventing genomic instability during DNA replication [41]. Additionally, the expression levels of RAD51 have been correlated with the repair capacity of cancer cells, suggesting that targeting RAD51 may enhance the efficacy of therapies that induce DNA damage [42].

Other proteins, such as RMI1, also contribute to the maintenance of genome stability by facilitating RAD51 recruitment to damaged DNA and promoting homologous recombination. RMI1's depletion has been shown to increase sensitivity to DNA-damaging agents, further emphasizing the collaborative nature of these proteins in the DNA repair process [43].

In summary, the DNA damage response involves a complex network of proteins, including BRCA1 and RAD51, which are crucial for the repair of DNA lesions and the maintenance of genomic stability. Their coordinated actions ensure that cells can effectively respond to DNA damage, thus preventing the accumulation of mutations and the development of cancer.

5 Consequences of DNA Damage Response Failure ​

5.1 Implications for Cancer Development ​

The DNA damage response (DDR) is a crucial set of signaling pathways that detect and repair DNA damage, thereby maintaining genomic stability. This stability is essential for normal cellular function, growth, and development. When cells encounter DNA damage—whether from endogenous sources, such as reactive oxygen species, or exogenous agents, such as radiation and chemicals—the DDR activates a coordinated series of responses that include cell cycle arrest, DNA repair, and, if damage is irreparable, programmed cell death (apoptosis) or senescence[3].

The DDR encompasses various pathways that specifically address different types of DNA lesions, particularly DNA double-strand breaks (DSBs), which are among the most severe forms of DNA damage. These pathways include homologous recombination (HR) and non-homologous end joining (NHEJ), both of which are vital for repairing DSBs and preventing genomic instability[44].

Failure of the DDR can have dire consequences. When the DDR is compromised, cells may accumulate unrepairable DNA damage, leading to genomic instability, which is a hallmark of cancer. Specifically, alterations in DDR pathways are strongly associated with the development and progression of various cancers, including ovarian cancer. For instance, it has been observed that approximately half of high-grade serous carcinomas (HGSCs) exhibit defects in DSB repair by HR, suggesting that these defects not only contribute to cancer onset but also to disease progression and chemoresistance[25].

Furthermore, mutations in key DDR genes, such as ARID1A, which are found in a significant percentage of endometrioid and clear cell carcinomas, can lead to deficiencies in DNA repair mechanisms, exacerbating the risk of cancer development[25]. This underscores the role of DDR in maintaining genomic integrity; its failure can facilitate the accumulation of mutations that drive tumorigenesis.

The implications of DDR failure extend beyond cancer development. It can also lead to resistance against chemotherapy and radiotherapy, as tumor cells with dysfunctional DDR pathways may survive DNA-damaging treatments that would otherwise induce cell death in normal cells[4]. For example, tumors often exploit aberrant DDR signaling to resist therapy, indicating that targeting the DDR could enhance the efficacy of cancer treatments by increasing the sensitivity of tumor cells to DNA-damaging agents[10].

In summary, the DDR plays a pivotal role in preserving genomic stability by effectively responding to DNA damage. Its failure not only contributes to the initiation and progression of cancer but also poses challenges in cancer therapy, highlighting the need for targeted strategies that can exploit these vulnerabilities in tumor cells.

5.2 Aging and Genomic Instability ​

The DNA damage response (DDR) plays a crucial role in maintaining genome stability, which is essential for cellular function, growth, and development. The DDR encompasses a complex signaling network that detects DNA damage, initiates repair processes, and coordinates cell cycle checkpoints to prevent the propagation of damaged DNA. This response is vital in safeguarding the integrity of the genome against various endogenous and exogenous stressors, including radiation and chemical agents, which can induce DNA lesions.

When DNA damage occurs, cells activate the DDR, leading to a series of cellular responses that include cell cycle arrest, DNA repair, senescence, or apoptosis if the damage is irreparable. The activation of the DDR is mediated by a variety of proteins that recognize DNA damage and signal for repair mechanisms to be initiated. For instance, proteins involved in homologous recombination repair play a significant role in maintaining genomic integrity, particularly in cancer cells, which often exhibit heightened genomic instability due to their reliance on these repair pathways to survive genotoxic stress (Lieberman and You, 2017) [12].

Failure of the DDR can lead to genomic instability, which is a hallmark of both aging and cancer. As cells age, the efficiency of the DDR declines, leading to an accumulation of DNA damage that contributes to functional decline in tissues and organs. The accumulation of unrepaired DNA damage is associated with age-related disorders, including neurodegenerative diseases and various forms of cancer (Crane et al., 2019) [45]. Specifically, the breakdown of the DDR during aging can result in altered cell cycle dynamics and increased genomic missegregation events, which further exacerbate the aging process (Edifizi et al., 2017) [46].

Moreover, the consequences of a dysfunctional DDR extend beyond individual cells, as systemic responses to DNA damage have been observed. These responses can include immune activation and inflammatory pathways that aim to clear damaged cells, but they can also contribute to the aging process and the development of age-related diseases (Soria-Valles et al., 2017) [47]. In this context, genomic instability not only affects the cellular level but also has implications for tissue homeostasis and organismal health.

In summary, the DDR is integral to maintaining genome stability through the detection and repair of DNA damage. However, as the efficiency of this response diminishes with age, the accumulation of DNA damage leads to genomic instability, contributing to the aging process and increasing susceptibility to age-related diseases. Understanding the mechanisms underlying DDR failure and its consequences is critical for developing therapeutic strategies aimed at mitigating the effects of aging and enhancing genomic stability.

5.3 Therapeutic Targets in DDR ​

The DNA damage response (DDR) is a crucial mechanism that maintains genomic stability by orchestrating a complex network of pathways involved in the detection, signaling, and repair of DNA lesions. This system is essential for preserving the integrity of genetic information, as DNA is continuously subjected to various types of damage, including single-strand breaks, double-strand breaks, and lesions caused by environmental factors. The DDR operates through several key processes, including damage sensing, signal transduction, repair pathway activation, and cell cycle regulation, ensuring that cells can effectively respond to DNA damage and maintain genomic stability [11][25].

When DNA damage occurs, specialized proteins are activated to recognize the type of damage and initiate appropriate repair mechanisms. For instance, the MRE11 complex plays a central role in processing DNA double-strand breaks, which are critical events that, if left unrepaired, can lead to genomic alterations and tumorigenesis [6]. The DDR also coordinates the cell cycle, temporarily halting progression to allow time for repair processes to occur [48]. This regulatory network ensures that damaged DNA is repaired before the cell divides, thus preventing the propagation of mutations.

Failure of the DDR can have severe consequences, including the accumulation of unrepaired DNA damage, leading to genomic instability. This instability is a hallmark of cancer, as it facilitates the development of tumors by promoting mutations and chromosomal aberrations [3][25]. In particular, defects in DDR pathways are associated with various cancers, including ovarian cancer, where approximately half of high-grade serous carcinomas exhibit deficiencies in DNA double-strand break repair [25]. Such failures not only contribute to cancer initiation but also to disease progression and chemoresistance, complicating treatment strategies [25].

Given the critical role of the DDR in maintaining genomic stability and its implications in cancer, it has become a significant focus for therapeutic targeting. Targeting DDR pathways offers the potential to exploit the vulnerabilities of cancer cells, particularly those with existing defects in their repair mechanisms. For example, PARP inhibitors have shown efficacy in treating cancers with homologous recombination repair deficiencies, such as those associated with BRCA mutations [49][50]. By inhibiting remaining DDR pathways, these therapies can sensitize tumor cells to genotoxic agents while sparing normal cells, thus minimizing side effects [51].

In addition to PARP inhibitors, ongoing research is exploring other DDR-targeting agents, including inhibitors of ATR, ATM, and CHK proteins, which play essential roles in the DDR [49]. These therapeutic strategies aim to enhance the effectiveness of existing treatments, including chemotherapy and radiotherapy, by combining them with DDR inhibitors to improve outcomes for patients with various cancers [50].

In summary, the DNA damage response is integral to maintaining genomic stability through a well-coordinated network of repair pathways. Failures in this system can lead to severe consequences, including cancer development and treatment resistance. Consequently, the DDR represents a promising target for novel therapeutic strategies aimed at enhancing cancer treatment efficacy and patient outcomes.

6 Interaction of DDR with Other Cellular Processes ​

6.1 Apoptosis and Senescence ​

The DNA damage response (DDR) is a critical mechanism that preserves genome stability by detecting and repairing DNA damage, which can arise from various internal and external stressors. The maintenance of genomic integrity is essential to prevent adverse cellular effects such as apoptosis, cellular senescence, and malignant transformation. The DDR operates through a complex signaling network that orchestrates a variety of cellular processes, including cell cycle regulation, DNA repair, and cell fate decisions such as apoptosis and senescence.

When DNA damage occurs, it activates the DDR pathways, which can lead to either the repair of the damage or the induction of programmed cell death (apoptosis) if the damage is deemed irreparable. Key proteins, such as p53, play a significant role in this process. p53 is known to induce the transcription of genes that negatively regulate cell cycle progression in response to DNA damage, thus contributing to genome stability by preventing the replication of damaged DNA [33]. Furthermore, p53 interacts with various cyclin-dependent kinase inhibitors (CDKIs) to modulate cell cycle progression and maintain genomic integrity [33].

In the context of apoptosis, the DDR can activate pathways that lead to programmed cell death, which serves to eliminate cells with significant DNA damage, thereby preventing the propagation of genomic instability. Apoptosis is the most well-studied form of cell death induced by DNA damage, but non-apoptotic forms of cell death also play a crucial role in the outcome of cellular responses to genotoxic stress [52]. The interplay between these different forms of cell death and the DDR is essential for effective tumor suppression and maintaining cellular homeostasis [52].

Moreover, the DDR is closely linked to cellular senescence, a state of permanent cell cycle arrest that acts as a protective mechanism against the propagation of damaged cells. Senescence can be triggered by persistent DNA damage and is characterized by changes in gene expression that prevent further division. This process is vital in preventing tumorigenesis, as it ensures that cells with damaged DNA do not continue to proliferate [3].

The coordination between the DDR, apoptosis, and senescence is influenced by various signaling pathways and cellular contexts. For instance, in adult stem cells, the response to DNA damage may differ significantly compared to other cell types, often leading to symmetric self-renewing divisions rather than apoptosis or senescence [53]. This unique response mechanism allows stem cells to maintain their population while managing DNA damage, thus playing a critical role in tissue homeostasis and longevity [53].

In summary, the DDR is a multifaceted signaling network that maintains genome stability by regulating DNA repair processes, apoptosis, and senescence. By orchestrating these cellular responses, the DDR plays a pivotal role in preventing the accumulation of genetic mutations that could lead to cancer and other diseases. Understanding the intricacies of the DDR and its interactions with apoptosis and senescence provides valuable insights into potential therapeutic strategies for various conditions, including cancer and age-related diseases.

6.2 Immune Response and DDR ​

The DNA damage response (DDR) is a critical cellular mechanism that ensures the maintenance of genomic stability by orchestrating a variety of processes, including DNA repair, cell cycle regulation, and interactions with the immune system. The DDR involves a complex network of signaling pathways that detect DNA damage and initiate repair mechanisms, thereby preventing the accumulation of mutations that could lead to diseases such as cancer.

At its core, the DDR comprises several key components: damage sensors, transducer kinases, and effector proteins. These components work together to detect DNA lesions and activate downstream signaling pathways that facilitate repair. For instance, the ATM and ATR kinases play pivotal roles in recognizing DNA damage and regulating cell cycle checkpoints, ensuring that cells do not progress through the cycle until damage is repaired [18]. This is crucial because uncorrected DNA damage can lead to genomic instability and the propagation of mutations in daughter cells.

The DDR also interacts intimately with the immune response. Recent studies have revealed that the DDR is not only involved in maintaining genomic integrity but also in modulating immune responses. Specifically, DDR components enhance cytosolic DNA sensing and stimulate the STING-dependent signaling pathway, which is crucial for innate immune responses [54]. Furthermore, DDR deficiencies can lead to aberrant immune responses, which may contribute to inflammation and tumorigenesis [55]. Conversely, effective DDR can enhance tumor-targeting immune responses, indicating a bidirectional relationship between DDR and immunity [56].

Moreover, the DDR is linked to the activation of various immune pathways that can either suppress or promote tumor growth, depending on the context. For example, DDR signaling can inhibit immune responses in cancer cells, allowing tumors to evade immune surveillance [56]. This complexity underscores the importance of understanding how DDR mechanisms can be leveraged to improve cancer therapies, particularly in combination with immunotherapies.

In addition to its role in the immune response, the DDR is essential for regulating cellular metabolism and stress responses. It has been shown that imbalances between DNA damage and repair can disrupt tissue homeostasis, leading to increased mutation rates and cellular senescence [54]. The interplay between DDR and metabolic pathways further highlights the multifaceted nature of DDR in maintaining cellular integrity.

Overall, the DDR is a vital system that not only preserves genomic stability but also interacts with other cellular processes, including the immune response. Understanding these interactions is crucial for developing new therapeutic strategies that exploit the DDR to enhance treatment efficacy, particularly in cancer [55][56].

6.3 Metabolic Regulation and DDR ​

The DNA damage response (DDR) plays a critical role in maintaining genome stability through a sophisticated and interconnected network of cellular processes. This network encompasses DNA repair mechanisms, cell cycle regulation, and metabolic adjustments that collectively ensure cellular homeostasis and genomic integrity under stress conditions.

Upon detection of DNA damage, cells activate the DDR, which halts cell cycle progression to allow for repair mechanisms to take effect. This activation involves a series of signaling pathways that coordinate the response to various types of DNA damage, including double-strand breaks. The protein kinases ATM (Ataxia Telangiectasia Mutated) and ATR (ATM and Rad3-related) are pivotal in this signaling network. They act as master regulators, responding to different types of DNA damage and orchestrating downstream processes that lead to either repair, senescence, or apoptosis in cases of irreparable damage [18].

The DDR is not an isolated event; it interacts extensively with cellular metabolism. Recent studies have shown that metabolic pathways are intricately linked to the DDR, particularly in how cells manage energy and resources during the repair process. For instance, mitochondrial glutamine metabolism has been identified as a crucial regulator of DNA damage-induced cell death. Inhibition of glutaminase, an enzyme involved in glutamine metabolism, sensitizes cancer cells to DNA damage by promoting the expression of amphiregulin, which facilitates apoptotic processes [57]. This highlights how metabolic reprogramming can influence the efficacy of the DDR and the overall fate of the cell.

Furthermore, the DDR can induce metabolic changes as part of its response to DNA damage. When DNA lesions are detected, cells undergo immediate metabolic shifts to support repair processes and maintain cellular homeostasis. These changes are facilitated by a network of regulators, including kinases and epigenetic factors, which modulate the activity of key proteins involved in the DDR [20]. This dynamic interplay ensures that the cellular environment is conducive to effective repair, thereby preventing genomic instability.

In addition to direct metabolic regulation, the DDR is also influenced by reactive oxygen species (ROS) generated during cellular metabolism. Neurons, for example, are particularly vulnerable to oxidative stress due to their high metabolic activity, which can lead to DNA damage. The DDR in neurons involves elaborate mechanisms to counteract oxidative damage, ensuring their longevity and functionality [3].

Moreover, the integration of DDR with other cellular processes, such as apoptosis and autophagy, further underscores its importance in maintaining genome stability. The decision to repair or eliminate damaged cells is crucial, as inappropriate responses can lead to genomic instability and the development of diseases such as cancer [12].

In summary, the DDR maintains genome stability through a coordinated response that integrates DNA repair mechanisms with metabolic regulation and other cellular processes. This intricate network ensures that cells can effectively respond to DNA damage, preserving genomic integrity and preventing the onset of diseases associated with genomic instability.

7 Conclusion ​

The DNA damage response (DDR) is a critical mechanism that preserves genome stability by orchestrating a series of complex signaling pathways involved in detecting and repairing DNA damage. Key findings from current research indicate that DDR components such as ATM, ATR, p53, BRCA1, and RAD51 play pivotal roles in maintaining genomic integrity and preventing the accumulation of mutations that can lead to cancer. Failures in these pathways can result in genomic instability, contributing to cancer development, aging, and treatment resistance. Furthermore, the DDR is intricately linked with other cellular processes, including apoptosis, senescence, immune responses, and metabolic regulation, highlighting its multifaceted role in cellular health. Future research should focus on elucidating the interactions between DDR pathways and other cellular processes to develop targeted therapies that exploit vulnerabilities in cancer cells while preserving normal cellular functions. By enhancing our understanding of the DDR, we can pave the way for innovative strategies to combat diseases associated with genomic instability, particularly cancer, and improve therapeutic outcomes for patients.

References ​

  • [1] Maher-Un Nisa;Ying Huang;Moussa Benhamed;Cécile Raynaud. The Plant DNA Damage Response: Signaling Pathways Leading to Growth Inhibition and Putative Role in Response to Stress Conditions.. Frontiers in plant science(IF=4.8). 2019. PMID:31164899. DOI: 10.3389/fpls.2019.00653.
  • [2] Bas Pilzecker;Olimpia Alessandra Buoninfante;Heinz Jacobs. DNA damage tolerance in stem cells, ageing, mutagenesis, disease and cancer therapy.. Nucleic acids research(IF=13.1). 2019. PMID:31251805. DOI: 10.1093/nar/gkz531.
  • [3] Ari Barzilai. DNA damage, neuronal and glial cell death and neurodegeneration.. Apoptosis : an international journal on programmed cell death(IF=8.1). 2010. PMID:20437103. DOI: 10.1007/s10495-010-0501-0.
  • [4] Emma Bolderson;Derek J Richard;Bin-Bing S Zhou;Kum Kum Khanna. Recent advances in cancer therapy targeting proteins involved in DNA double-strand break repair.. Clinical cancer research : an official journal of the American Association for Cancer Research(IF=10.2). 2009. PMID:19808869. DOI: 10.1158/1078-0432.CCR-09-0096.
  • [5] Y Shiloh. ATM and ATR: networking cellular responses to DNA damage.. Current opinion in genetics & development(IF=3.6). 2001. PMID:11163154. DOI: 10.1016/s0959-437x(00)00159-3.
  • [6] Travis H Stracker;John H J Petrini. The MRE11 complex: starting from the ends.. Nature reviews. Molecular cell biology(IF=90.2). 2011. PMID:21252998. DOI: 10.1038/nrm3047.
  • [7] Ruoxi Wang;Yating Sun;Chunshuang Li;Yaoyao Xue;Xueqing Ba. Targeting the DNA Damage Response for Cancer Therapy.. International journal of molecular sciences(IF=4.9). 2023. PMID:37958890. DOI: 10.3390/ijms242115907.
  • [8] Xuewei Cui;Ye Wang;Jianhua Fu. DNA damage response and cell fate decisions across the lifespan: from fetal development to age-related respiratory diseases.. Cell & bioscience(IF=6.2). 2025. PMID:40753255. DOI: 10.1186/s13578-025-01442-6.
  • [9] J M Bradbury;S P Jackson. The complex matter of DNA double-strand break detection.. Biochemical Society transactions(IF=4.3). 2003. PMID:12546650. DOI: 10.1042/bst0310040.
  • [10] Hui Tian;Zhen Gao;HuiZhong Li;BaoFu Zhang;Gang Wang;Qing Zhang;DongSheng Pei;JunNian Zheng. DNA damage response--a double-edged sword in cancer prevention and cancer therapy.. Cancer letters(IF=10.1). 2015. PMID:25528631. DOI: .
  • [11] Antonio Carusillo;Claudio Mussolino. DNA Damage: From Threat to Treatment.. Cells(IF=5.2). 2020. PMID:32664329. DOI: 10.3390/cells9071665.
  • [12] Rachel Lieberman;Ming You. Corrupting the DNA damage response: a critical role for Rad52 in tumor cell survival.. Aging(IF=3.9). 2017. PMID:28722656. DOI: 10.18632/aging.101263.
  • [13] Susanna Ambrosio;Anna Noviello;Giovanni Di Fusco;Francesca Gorini;Anna Piscone;Stefano Amente;Barbara Majello. Interplay and Dynamics of Chromatin Architecture and DNA Damage Response: An Overview.. Cancers(IF=4.4). 2025. PMID:40149285. DOI: 10.3390/cancers17060949.
  • [14] Nadja Bitomsky;Thomas G Hofmann. Apoptosis and autophagy: Regulation of apoptosis by DNA damage signalling - roles of p53, p73 and HIPK2.. The FEBS journal(IF=4.2). 2009. PMID:19788416. DOI: 10.1111/j.1742-4658.2009.07331.x.
  • [15] Sentiljana Gumeni;Zoi Evangelakou;Vassilis G Gorgoulis;Ioannis P Trougakos. Proteome Stability as a Key Factor of Genome Integrity.. International journal of molecular sciences(IF=4.9). 2017. PMID:28937603. DOI: 10.3390/ijms18102036.
  • [16] Nathalie Durut;Ortrun Mittelsten Scheid. The Role of Noncoding RNAs in Double-Strand Break Repair.. Frontiers in plant science(IF=4.8). 2019. PMID:31611891. DOI: 10.3389/fpls.2019.01155.
  • [17] Luke A Yates. Regulation of DNA break repair by RNA.. Progress in biophysics and molecular biology(IF=4.5). 2021. PMID:33385412. DOI: 10.1016/j.pbiomolbio.2020.12.005.
  • [18] Alexandre Maréchal;Lee Zou. DNA damage sensing by the ATM and ATR kinases.. Cold Spring Harbor perspectives in biology(IF=8.4). 2013. PMID:24003211. DOI: .
  • [19] André Nussenzweig. Causes and consequences of the DNA damage response.. Cell cycle (Georgetown, Tex.)(IF=3.4). 2007. PMID:17914283. DOI: 10.4161/cc.6.19.4995.
  • [20] Yunhua Liu;Yujing Li;Xiongbin Lu. Regulators in the DNA damage response.. Archives of biochemistry and biophysics(IF=3.0). 2016. PMID:26882840. DOI: .
  • [21] R E Shackelford;W K Kaufmann;R S Paules. Cell cycle control, checkpoint mechanisms, and genotoxic stress.. Environmental health perspectives(IF=9.8). 1999. PMID:10229703. DOI: 10.1289/ehp.99107s15.
  • [22] Ja-Eun Kim;Katherine Minter-Dykhouse;Junjie Chen. Signaling networks controlled by the MRN complex and MDC1 during early DNA damage responses.. Molecular carcinogenesis(IF=3.2). 2006. PMID:16691596. DOI: 10.1002/mc.20221.
  • [23] Huasong Lu;Min Yang;Qiang Zhou. Reprogramming transcription after DNA damage: recognition, response, repair, and restart.. Trends in cell biology(IF=18.1). 2023. PMID:36513571. DOI: 10.1016/j.tcb.2022.11.010.
  • [24] Wenjian Gan;Pengda Liu;Wenyi Wei. Akt promotes tumorigenesis in part through modulating genomic instability via phosphorylating XLF.. Nucleus (Austin, Tex.)(IF=4.5). 2015. PMID:26225792. DOI: 10.1080/19491034.2015.1074365.
  • [25] María Ovejero-Sánchez;Rogelio González-Sarmiento;Ana Belén Herrero. DNA Damage Response Alterations in Ovarian Cancer: From Molecular Mechanisms to Therapeutic Opportunities.. Cancers(IF=4.4). 2023. PMID:36672401. DOI: 10.3390/cancers15020448.
  • [26] Anika Maria Weber;Anderson Joseph Ryan. ATM and ATR as therapeutic targets in cancer.. Pharmacology & therapeutics(IF=12.5). 2015. PMID:25512053. DOI: .
  • [27] Andrew N Blackford;Stephen P Jackson. ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response.. Molecular cell(IF=16.6). 2017. PMID:28622525. DOI: 10.1016/j.molcel.2017.05.015.
  • [28] Vanessa Enriquez-Rios;Lavinia C Dumitrache;Susanna M Downing;Yang Li;Eric J Brown;Helen R Russell;Peter J McKinnon. DNA-PKcs, ATM, and ATR Interplay Maintains Genome Integrity during Neurogenesis.. The Journal of neuroscience : the official journal of the Society for Neuroscience(IF=4.0). 2017. PMID:28123024. DOI: 10.1523/JNEUROSCI.4213-15.2016.
  • [29] Demis Menolfi;Shan Zha. ATM, ATR and DNA-PKcs kinases-the lessons from the mouse models: inhibition ≠ deletion.. Cell & bioscience(IF=6.2). 2020. PMID:32015826. DOI: 10.1186/s13578-020-0376-x.
  • [30] Karlene A Cimprich;David Cortez. ATR: an essential regulator of genome integrity.. Nature reviews. Molecular cell biology(IF=90.2). 2008. PMID:18594563. DOI: 10.1038/nrm2450.
  • [31] Yosef Shiloh. ATM and related protein kinases: safeguarding genome integrity.. Nature reviews. Cancer(IF=66.8). 2003. PMID:12612651. DOI: 10.1038/nrc1011.
  • [32] Han Zhang;Jianxiong Xu;Yuxuan Long;Ayitila Maimaitijiang;Zhengding Su;Wenfang Li;Jinyao Li. Unraveling the Guardian: p53's Multifaceted Role in the DNA Damage Response and Tumor Treatment Strategies.. International journal of molecular sciences(IF=4.9). 2024. PMID:39684639. DOI: 10.3390/ijms252312928.
  • [33] Adnan Erol. Genotoxic stress-mediated cell cycle activities for the decision of cellular fate.. Cell cycle (Georgetown, Tex.)(IF=3.4). 2011. PMID:21921675. DOI: 10.4161/cc.10.19.17460.
  • [34] Sara Nicolai;Antonello Rossi;Nicola Di Daniele;Gerry Melino;Margherita Annicchiarico-Petruzzelli;Giuseppe Raschellà. DNA repair and aging: the impact of the p53 family.. Aging(IF=3.9). 2015. PMID:26668111. DOI: 10.18632/aging.100858.
  • [35] Francis Rodier;Judith Campisi;Dipa Bhaumik. Two faces of p53: aging and tumor suppression.. Nucleic acids research(IF=13.1). 2007. PMID:17942417. DOI: 10.1093/nar/gkm744.
  • [36] Pavana Lakshmi Vaddavalli;Björn Schumacher. The p53 network: cellular and systemic DNA damage responses in cancer and aging.. Trends in genetics : TIG(IF=16.3). 2022. PMID:35346511. DOI: 10.1016/j.tig.2022.02.010.
  • [37] Ashley B Williams;Björn Schumacher. p53 in the DNA-Damage-Repair Process.. Cold Spring Harbor perspectives in medicine(IF=10.1). 2016. PMID:27048304. DOI: .
  • [38] Kienan I Savage;Julia J Gorski;Eliana M Barros;Gareth W Irwin;Lorenzo Manti;Alexander J Powell;Andrea Pellagatti;Natalia Lukashchuk;Dennis J McCance;W Glenn McCluggage;Giuseppe Schettino;Manuel Salto-Tellez;Jacqueline Boultwood;Derek J Richard;Simon S McDade;D Paul Harkin. Identification of a BRCA1-mRNA splicing complex required for efficient DNA repair and maintenance of genomic stability.. Molecular cell(IF=16.6). 2014. PMID:24746700. DOI: .
  • [39] Madalena Tarsounas;Adelina A Davies;Stephen C West. RAD51 localization and activation following DNA damage.. Philosophical transactions of the Royal Society of London. Series B, Biological sciences(IF=4.7). 2004. PMID:15065660. DOI: 10.1098/rstb.2003.1368.
  • [40] K Gudmundsdottir;A Ashworth. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability.. Oncogene(IF=7.3). 2006. PMID:16998501. DOI: 10.1038/sj.onc.1209874.
  • [41] Manuel Daza-Martin;Katarzyna Starowicz;Mohammed Jamshad;Stephanie Tye;George E Ronson;Hannah L MacKay;Anoop Singh Chauhan;Alexandra K Walker;Helen R Stone;James F J Beesley;Jennifer L Coles;Alexander J Garvin;Grant S Stewart;Thomas J McCorvie;Xiaodong Zhang;Ruth M Densham;Joanna R Morris. Isomerization of BRCA1-BARD1 promotes replication fork protection.. Nature(IF=48.5). 2019. PMID:31270457. DOI: 10.1038/s41586-019-1363-4.
  • [42] Mariam Gachechiladze;Josef Škarda;Alex Soltermann;Markus Joerger. RAD51 as a potential surrogate marker for DNA repair capacity in solid malignancies.. International journal of cancer(IF=4.7). 2017. PMID:28477336. DOI: 10.1002/ijc.30764.
  • [43] Lianying Fang;Xiaohui Sun;Yan Wang;Liqing Du;Kaihua Ji;Jinhan Wang;Ningning He;Yang Liu;Qin Wang;Hezheng Zhai;Jianxiu Hao;Chang Xu;Qiang Liu. RMI1 contributes to DNA repair and to the tolerance to camptothecin.. FASEB journal : official publication of the Federation of American Societies for Experimental Biology(IF=4.2). 2019. PMID:30676768. DOI: 10.1096/fj.201802014R.
  • [44] Gang Li;Dengqin He;Xiaojia Cai;Wen Guan;Yali Zhang;Jia-Qiang Wu;Hongliang Yao. Advances in the development of phosphodiesterase-4 inhibitors.. European journal of medicinal chemistry(IF=5.9). 2023. PMID:36809706. DOI: 10.1016/j.ejmech.2023.115195.
  • [45] Matthew M Crane;Adam E Russell;Brent J Schafer;Ben W Blue;Riley Whalen;Jared Almazan;Mung Gi Hong;Bao Nguyen;Joslyn E Goings;Kenneth L Chen;Ryan Kelly;Matt Kaeberlein. DNA damage checkpoint activation impairs chromatin homeostasis and promotes mitotic catastrophe during aging.. eLife(IF=6.4). 2019. PMID:31714209. DOI: .
  • [46] Diletta Edifizi;Hendrik Nolte;Vipin Babu;Laia Castells-Roca;Michael M Mueller;Susanne Brodesser;Marcus Krüger;Björn Schumacher. Multilayered Reprogramming in Response to Persistent DNA Damage in C. elegans.. Cell reports(IF=6.9). 2017. PMID:28854356. DOI: 10.1016/j.celrep.2017.08.028.
  • [47] Clara Soria-Valles;Alejandro López-Soto;Fernando G Osorio;Carlos López-Otín. Immune and inflammatory responses to DNA damage in cancer and aging.. Mechanisms of ageing and development(IF=5.1). 2017. PMID:27720808. DOI: 10.1016/j.mad.2016.10.004.
  • [48] G Raschellà;G Melino;M Malewicz. New factors in mammalian DNA repair-the chromatin connection.. Oncogene(IF=7.3). 2017. PMID:28394347. DOI: 10.1038/onc.2017.60.
  • [49] Anna Minchom;Caterina Aversa;Juanita Lopez. Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies.. Therapeutic advances in medical oncology(IF=4.2). 2018. PMID:30023007. DOI: 10.1177/1758835918786658.
  • [50] Yvette Drew;Frank T Zenke;Nicola J Curtin. DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications.. Nature reviews. Drug discovery(IF=101.8). 2025. PMID:39533099. DOI: 10.1038/s41573-024-01060-w.
  • [51] Michael Biss;Wei Xiao. Selective tumor killing based on specific DNA-damage response deficiencies.. Cancer biology & therapy(IF=4.6). 2012. PMID:22258411. DOI: 10.4161/cbt.18921.
  • [52] Evgeniia A Prokhorova;Aleksandra Yu Egorshina;Boris Zhivotovsky;Gelina S Kopeina. The DNA-damage response and nuclear events as regulators of nonapoptotic forms of cell death.. Oncogene(IF=7.3). 2020. PMID:31462710. DOI: 10.1038/s41388-019-0980-6.
  • [53] Alessandra Insinga;Angelo Cicalese;Mario Faretta;Barbara Gallo;Luisa Albano;Simona Ronzoni;Laura Furia;Andrea Viale;Pier Giuseppe Pelicci. DNA damage in stem cells activates p21, inhibits p53, and induces symmetric self-renewing divisions.. Proceedings of the National Academy of Sciences of the United States of America(IF=9.1). 2013. PMID:23417300. DOI: 10.1073/pnas.1213394110.
  • [54] Zu Ye;Yin Shi;Susan P Lees-Miller;John A Tainer. Function and Molecular Mechanism of the DNA Damage Response in Immunity and Cancer Immunotherapy.. Frontiers in immunology(IF=5.9). 2021. PMID:34970273. DOI: 10.3389/fimmu.2021.797880.
  • [55] Thomas J Hayman;Peter M Glazer. Regulation of the Cell-Intrinsic DNA Damage Response by the Innate Immune Machinery.. International journal of molecular sciences(IF=4.9). 2021. PMID:34884568. DOI: 10.3390/ijms222312761.
  • [56] Vanessa Klapp;Beatriz Álvarez-Abril;Giuseppe Leuzzi;Guido Kroemer;Alberto Ciccia;Lorenzo Galluzzi. The DNA Damage Response and Inflammation in Cancer.. Cancer discovery(IF=33.3). 2023. PMID:37026695. DOI: 10.1158/2159-8290.CD-22-1220.
  • [57] Sunsook Hwang;Seungyeon Yang;Minjoong Kim;Youlim Hong;Byungjoo Kim;Eun Kyung Lee;Seung Min Jeong. Mitochondrial glutamine metabolism regulates sensitivity of cancer cells after chemotherapy via amphiregulin.. Cell death discovery(IF=7.0). 2021. PMID:34924566. DOI: 10.1038/s41420-021-00792-7.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

DNA Damage Response · Genome Stability · Cancer Development · Cell Cycle Regulation · Key Proteins

© 2025 MaltSci